Providing advice & guidance for tech and digital scale up brands to expand internationally & support companies looking to land & expand into the Greater Phoenix region USA

Chris has over 30 years of experience in key sectors such as MedTech devices, Pharma, Bio Pharma, CRO and Academia. He has great access to mission-critical clinical trial and evaluator channels as well as funding, investment, government, and regulatory bodies and networks.

Frederick In charge of identifying and assisting foreign companies in setting up new operations in the canton of Vaud - Switzerland. Specialised in the field of healthcare, his role is to provide customised services to support life science & foodtech companies in establishing and developing their business in the region.

Frederick is a Key Account Manager at Innovaud, the innovation agency for the canton of Vaud in Switzerland’s Lake Geneva region. He supports foreign companies wanting to establish a presence in the heart of Europe.

Yannis is a Deputy Head Swiss Business Hub UK + Ireland at Swiss Embassy, the Official Channel of the Federal Department of Foreign Affairs FDFA.

Guillaume is a partner at Schellenberg Wittmer. He deals with cases involving international tax, banking, estate and art law, most often between Switzerland and the UK, the USA, the Middle East or China. He advises his clients in such matters as tax and estate planning (trusts, life insurances, foundations, wills, prenuptial and postnuptial agreements, etc.).

Oliver is a Director of Business Development & Corporate Relations at Biopôle SA. Oilver has 20 years of sales and business development experience for SMEs in complex, high tech and scientific environments, with 15 years of international exposure.

Tony is the CEO of One Nucleus, a membership organisation for international life science and healthcare companies with basis in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.

Anna is a Founder of Impli, a biotech company founded in April 2019 to make people’s lives safer and healthier using implantable technology.

Thomas is a Senior Manager - R&D at Frazier & Deeter UK, a firm providing advisory services to mid-market businesses, with expertise in supporting cross-border businesses.

Malcolm is the Lead Partner of Frazier & Deeter UK, a firm providing advisory services to mid-market businesses, with expertise in supporting cross-border businesses. In addition to leading the firm’s growth in the UK, Malcolm is responsible for tax advisory services and transaction advisory services. Malcolm is also the Global Leader of Transfer Pricing Services at Frazier & Deeter.

Steve is an experienced Research and Development leader, holding roles in Dyson, Reckitt, GSK consumer healthcare and Haleon. He is developing innovative technology products in consumer health.

30 years of experience in the discovery & diagnosis of novel treatments for diseases with unmet medical needs. Formerly at Pfizer, doing research into neurodegenerative diseases in the UK. Subsequently, set up Cambridge Drug Discovery in 1997 and sold it in 2001. Since then, helped to raise £300mln for life sciences companies, and enabled inward investment into the UK of £6bln.

Kate has extensive experience in R&D roles at Unilever and GSK Consumer Healthcare. She has considerable expertise in delivering tactical and strategic innovation from early stage idea to launch by aligning consumer insight with science.